Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: a clinical phase IIB trial.

Mesia K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Musuamba T, Mets T, Cimanga K, Totté J, Pieters L, Vlietinck AJ.

Planta Med. 2012 Jun;78(9):853-60. doi: 10.1055/s-0031-1298488. Epub 2012 Apr 26.

PMID:
22538476
2.

Antimalarial efficacy of a quantified extract of Nauclea pobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 1: a clinical phase IIA trial.

Mesia K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Cimanga K, Totté J, Mets T, Pieters L, Vlietinck AJ.

Planta Med. 2012 Feb;78(3):211-8. doi: 10.1055/s-0031-1280359. Epub 2011 Nov 17.

PMID:
22095262
3.

Assessment of the short-term safety and tolerability of a quantified 80 % ethanol extract from the stem bark of Nauclea pobeguinii (PR 259 CT1) in healthy volunteers: a clinical phase I study.

Mesia K, Cimanga K, Tona L, Mampunza MM, Ntamabyaliro N, Muanda T, Muyembe T, Totté J, Mets T, Pieters L, Vlietinck A.

Planta Med. 2011 Jan;77(2):111-6. doi: 10.1055/s-0030-1250134. Epub 2010 Jul 21.

PMID:
20665369
4.

Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.

Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Tambo E, Fateye BA, Happi TC, Oduola AM.

Trop Med Int Health. 2005 Nov;10(11):1161-70.

5.

A randomized trial of amodiaquine and artesunate alone and in combination for the treatment of uncomplicated falciparum malaria in children from Burkina Faso.

Barennes H, Nagot N, Valea I, Koussoubé-Balima T, Ouedraogo A, Sanou T, Yé S.

Trop Med Int Health. 2004 Apr;9(4):438-44.

6.

Pharmacokinetics and pharmacodynamics of a new ACT formulation: Artesunate/Amodiaquine (TRIMALACT) following oral administration in African malaria patients.

Sinou V, Malaika LT, Taudon N, Lwango R, Alegre SS, Bertaux L, Sugnaux F, Parzy D, Benakis A.

Eur J Drug Metab Pharmacokinet. 2009 Jul-Sep;34(3-4):133-42.

PMID:
20166428
7.

Efficacy of artesunate-amodiaquine for the treatment of acute uncomplicated falciparum malaria in southern Mauritania.

Ouldabdallahi M, Alew I, Salem MS, Dit Dialaw Ba M, Boukhary AO, Khairy ML, Aziz MB, Ringwald P, Basco LK, Niang SD, Lebatt SM.

Malar J. 2014 Dec 16;13:496. doi: 10.1186/1475-2875-13-496.

8.

Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.

Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD.

Malar J. 2009 May 19;8:107. doi: 10.1186/1475-2875-8-107.

9.

Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C.

Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12.

PMID:
17051490
10.

Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast.

Faye B, Offianan AT, Ndiaye JL, Tine RC, Touré W, Djoman K, Sylla K, Ndiaye PS, Penali L, Gaye O.

Trop Med Int Health. 2010 May;15(5):608-13. doi: 10.1111/j.1365-3156.2010.02487.x. Epub 2010 Mar 1.

12.

Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.

Karbwang J, Na-Bangchang K, Thanavibul A, Bunnag D, Chongsuphajaisiddhi T, Harinasuta T.

Bull World Health Organ. 1994;72(2):233-8.

13.

An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.

Silachamroon U, Krudsood S, Thanachartwet W, Tangpukdee N, Leowattana W, Chalermrut K, Srivilairit S, Wilaiaratana P, Thimasarn K, Looareesuwan S.

Southeast Asian J Trop Med Public Health. 2005 May;36(3):591-6.

PMID:
16124422
16.
17.

Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria.

Ndiaye JL, Faye B, Diouf AM, Kuété T, Cisse M, Seck PA, Brasseur P, Same-Ekobo A, Lameyre V, Gaye O.

Malar J. 2008 Jan 19;7:16. doi: 10.1186/1475-2875-7-16.

18.

In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.

Thwing JI, Odero CO, Odhiambo FO, Otieno KO, Kariuki S, Ord R, Roper C, McMorrow M, Vulule J, Slutsker L, Newman RD, Hamel MJ, Desai M.

Trop Med Int Health. 2009 Mar;14(3):294-300. doi: 10.1111/j.1365-3156.2009.02222.x. Epub 2009 Jan 28.

Supplemental Content

Support Center